ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: musculoskeletal disease

Ultrasound Training Tips & Pitfalls

Eugene Kissin, MD, RhMSUS; Paul J. DeMarco, MD, FACP, FACR, RhMSUS; Daniel G. Malone, MD, RMSK; Catherine Bakewell, MD, RhMSUS; Karina Torralba, MD, FACR, CCD, RhMSUS; Rany al Haj, MD; Narandra Bethina, MD, RhMSUS; Clara Lin, MD, RhMSUS; Amy M. Evangelisto, MD, RhMSUS; Jay Higgs, MD, RhMSUS; & Midori Jane Nishio, MD, RhMSUS  |  

The past 20 years have seen dramatic changes in the practice of rheumatology, ranging from bench to bedside therapeutic advances to dramatic improvements in diagnostic imaging. The results have been gratifying for our patients and attractive to internal medicine trainees making subspecialty career decisions. We are pleased to provide this article for The Rheumatologist’s wide-ranging…

Interferon Score Predicts AI-CTDs

  |  

People with autoimmune connective tissue diseases produce antibodies against nuclear antigens up to 10 years before they develop clinical features. Anti-nuclear antibodies (ANAs) are also very common, and a small percentage of ANA-positive patients progress to clinical autoimmunity. The question: Is there a reliable way to screen at-risk patients before they develop active autoimmunity and…

New Joint Space Mapping Technique Doubles Diagnostic Sensitivity for Osteoarthritis

Renée Bacher  |  

Traditional X-rays, move over—there may be a new gold standard for joint imaging to assess even the smallest changes that can signal the onset of arthritis, as reported recently in the journal Scientific Reports.1 Utilizing the combined expertise of radiologists, rheumatologists and engineers, University of Cambridge researchers developed an algorithm to monitor the joints of…

Biomarkers for Knee OA

  |  

Knee osteoarthritis (OA) accounts for more than 80% of OA disease burden and has doubled in prevalence in the mid-20th century in the U.S. when compared with people who lived during early industrial era (1800s to early 1900s).1 Currently, the diagnostic and treatment armamentaria are limited. Disease progression is measured by joint space narrowing on…

ACR Leaders Outline Advocacy Victories, Threats

Thomas R. Collins  |  

CHICAGO—ACR leaders described a series of looming legislative and regulatory threats to rheumatologists and their patients—including the proposed collapsing of evaluation and management (E/M) coding and potential changes to step therapy rules—and urged everyone in the field to make their voices heard to quash the proposals. They also recounted recent victories in the policy realm…

Awards, Appointments & Announcements in the World of Rheumatology

  |  

Canadian Pediatric Rheumatologist Invested into Order of Canada Peter Dent, MD, professor emeritus of pediatrics at McMaster University in Hamilton, Ontario, Canada, was invested into the Order of Canada in May. The Order of Canada is the country’s highest civilian honor. “Dr. Dent has had a substantial positive impact on healthcare, in Hamilton and far…

Pulmonary Compromise Leads to Relapsing Polychondritis Diagnosis

Marcela A. Ferrada, MD, Anjali Takyar, MD, & James D. Katz, MD  |  

Relapsing polychondritis (RPC) is a systemic and, in some cases, fatal disease. Dyspnea with findings of small airway disease—even in the absence of the more commonly associated tracheobronchial abnormalities or pathognomonic clinical findings, such as saddle nose and cauliflower ear—may be presenting signs and symptoms of relapsing polychondritis. Below, we present a case demonstrating that…

Taking Vitamin D Supplements May Not Improve Bone Health

Linda Carroll  |  

(Reuters Health)—Vitamin D supplementation may not improve bone density or prevent fractures and falls in adults, a large new analysis suggests. After combining data from 81 randomized controlled trials, researchers found no bone benefits from supplementing the vitamin, according to the report in The Lancet Diabetes & Endocrinology, online October 4. “Our results show that…

Immune Checkpoint Inhibitors & Immune-Related Adverse Events

Priya Chokshi, MD, Roberta Seidman, MD, Noah Levit, PhD, MD, & Steven E. Carsons, MD  |  

Immune checkpoint inhibitors (ICIs) are at the forefront of advances in cancer therapy and have shown promising results for progression-free survival. Checkpoint signaling pathways, such as cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1), normally regulate the immune response to promote self-tolerance and prevent tissue damage and inflammation. PD-1 is a…

New Study Aimed at Better Predicting Large Vessel Vasculitis Relapse

Elizabeth Hofheinz, MPH, MEd  |  

Imagine telling a patient “You’re in remission!” and finding out it’s not true. The last thing you want to do is get it wrong clinically and put your patient on an emotional rollercoaster. With large vessel vasculitis (LVV) in particular, physicians struggle to be accurate, to determine if indeed the disease has gone away or…